Analyst: Cronos And Altria Make A Powerful Team

Cronos Group Inc CRON CEO Mike Gorenstein presented Tuesday at the Consumer Analyst Group of New York lunch. After attending the event, one Wall Street analyst said Cronos could become a “crown JUUL” of the cannabis business.

The Analyst

Wells Fargo analyst Bonnie Herzog reiterated her Outperform rating and $65 price target for Cronos stock.

The Thesis

Cronos’ Canadian distribution now reaches about 60 percent of the population and is still growing, however, Gorenstein said establishing infrastructure for edibles, beverages and vaping products in the Canadian market may take longer than investors think. Cronos plans to launch its first CBD vape product by next January.

Need more cannabis news? Check out all of our coverage here.

Cronos’ partnership with Altria Group Inc MO prohibits Cronos from other tobacco partnerships, but Altria would likely benefit from additional food, beverage and pharma partnerships for Cronos. Gorenstein said tobacco volumes are declining with or without cannabis and doesn't believe there's a major risk of tobacco cannibalization.

Herzog said the combination of Altria, JUUL and Cronos should be a profitable one for investors.

“As with JUUL, we believe MO’s expertise in regulatory, marketing and brand mgmt matters will help CRON to accelerate its growth esp with regard to developing cannabis vape products, large scale mfg automation, preroll technology & supply chain mgmt,” Herzog wrote in the note.

In the long term, Cronos management expects a wide range of margins across the industry, but sustainable 70 percent margins are unlikely. Gorenstein isn’t necessarily convinced the first global cannabis brand will be a Canadian company.

Price Action

Cronos shares surged 8 percent to $15.62 on Wednesday morning.

Related Links:

Bank Of America Double Upgrades Cronos, Says Bear Thesis 'Increasingly Untenable'

Cronos Group's Stock May Have Finally Found Technical Support

Posted In: Bonnie HerzogJUULJuul LabsWells FargoAnalyst ColorCannabisReiterationTop StoriesMarketsAnalyst Ratings

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.